Immunology of hepatitis C virus infections

Best Practice and Research: Clinical Gastroenterology

Volumn 26, Issue 4, 2012, Pages 391-400

  Spaan, Michelle ^a   Janssen, Harry L A ^a   Boonstra, Andre ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

HCV; Hepatitis C virus; Immunology; Liver

Indexed keywords

ALPHA INTERFERON; BOCEPREVIR; CYTOKINE; INTERFERON; INTERLEUKIN 10; PROTEINASE INHIBITOR; RIBAVIRIN; TELAPREVIR; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LIVER CELL; NATURAL KILLER CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; VIRUS REPLICATION;

EID: 84870466702     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2012.09.005     Document Type: Article

References (100)

1. C. Conry-Cantilena, M. VanRaden, J. Gibble, J. Melpolder, A.O. Shakil, and L. Viladomiu Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection N Engl J Med 334 26 1996 Jun 27 1691 1696
2. M.J. Alter, D. Kruszon-Moran, O.V. Nainan, G.M. McQuillan, F. Gao, and L.A. Moyer The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 8 1999 Aug 19 556 562
3. C.W. Shepard, L. Finelli, and M.J. Alter Global epidemiology of hepatitis C virus infection Lancet Infect Dis 5 9 2005 Sep 558 567
4. R.S. Brown Hepatitis C and liver transplantation Nature 436 7053 2005 Aug 18 973 978
5. L.B. Dustin, and C.M. Rice Flying under the radar: the immunobiology of hepatitis C Annu Rev Immunol 25 2007 71 99
6. B. Rehermann, and M. Nascimbeni Immunology of hepatitis B virus and hepatitis C virus infection Nat Rev Immunol 5 3 2005 Mar 215 229
7. A. Boonstra, A.M. Woltman, and H.L. Janssen Immunology of hepatitis B and hepatitis C virus infections Best Pract Res Clin Gastroenterol 22 6 2008 1049 1061
8. D. Novick, B. Cohen, and M. Rubinstein The human interferon alpha/beta receptor: characterization and molecular cloning Cell. 77 3 1994 May 6 391 400
9. A. Garcia-Sastre, and C.A. Biron Type 1 interferons and the virus-host relationship: a lesson in detente Science 312 5775 2006 May 12 879 882
10. A.J. Sadler, and B.R. Williams Interferon-inducible antiviral effectors Nat Rev Immunol 8 7 2008 Jul 559 568
11. A. Boonstra, L.J. van der Laan, T. Vanwolleghem, and H.L. Janssen Experimental models for hepatitis C viral infection Hepatology 50 5 2009 Nov 1646 1655
12. T. Saito, D.M. Owen, F. Jiang, J. Marcotrigiano, and M. Gale Jr. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA Nature 454 7203 2008 Jul 24 523 527
13. K. Li, N.L. Li, D. Wei, S.R. Pfeffer, M. Fan, and L.M. Pfeffer Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates Hepatology 55 3 2012 Mar 666 675
14. M. Gale Jr., and E.M. Foy Evasion of intracellular host defence by hepatitis C virus Nature 436 7053 2005 Aug 18 939 945
15. M.U. Mondelli, S. Varchetta, and B. Oliviero Natural killer cells in viral hepatitis: facts and controversies Eur J Clin Invest 40 9 2010 Sep 851 863
16. K. Cheent, and S.I. Khakoo Natural killer cells and hepatitis C: action and reaction Gut 60 2 2011 Feb 268 278
17. T.P. Salazar-Mather, C.A. Lewis, and C.A. Biron Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver J Clin Invest 110 3 2002 Aug 321 330
18. E. Vivier, D.H. Raulet, A. Moretta, M.A. Caligiuri, L. Zitvogel, and L.L. Lanier Innate or adaptive immunity? The example of natural killer cells Science 331 6013 2011 Jan 7 44 49
19. S.I. Khakoo, C.L. Thio, M.P. Martin, C.R. Brooks, X. Gao, and J. Astemborski HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection Science 305 5685 2004 Aug 6 872 874
20. S. Crotta, A. Stilla, A. Wack, A. D'Andrea, S. Nuti, and U. D'Oro Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein J Exp Med 195 1 2002 Jan 7 35 41
21. C.T. Tseng, and G.R. Klimpel Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions J Exp Med 195 1 2002 Jan 7 43 49
22. J.C. Yoon, M. Shiina, G. Ahlenstiel, and B. Rehermann Natural killer cell function is intact after direct exposure to infectious hepatitis C virions Hepatology 49 1 2009 Jan 12 21
23. B. Amadei, S. Urbani, A. Cazaly, P. Fisicaro, A. Zerbini, and P. Ahmed Activation of natural killer cells during acute infection with hepatitis C virus Gastroenterology 138 4 2010 Apr 1536 1545
24. S. Pelletier, C. Drouin, N. Bedard, S.I. Khakoo, J. Bruneau, and N.H. Shoukry Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses J Hepatol 53 5 2010 Nov 805 816
25. B. Oliviero, S. Varchetta, E. Paudice, G. Michelone, M. Zaramella, and D. Mavilio Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections Gastroenterology 137 3 2009 Sep 1151 1160 60 e1-7
26. G. Ahlenstiel, R.H. Titerence, C. Koh, B. Edlich, J.J. Feld, and Y. Rotman Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner Gastroenterology 138 1 2010 Jan 325 335 e1-2
27. M. Jinushi, T. Takehara, T. Tatsumi, T. Kanto, T. Miyagi, and T. Suzuki Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection J Immunol 173 10 2004 Nov 15 6072 6081
28. T. Miyagi, T. Takehara, K. Nishio, S. Shimizu, K. Kohga, and W. Li Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection J Hepatol 53 3 2010 Sep 424 430
29. B. Kramer, C. Korner, M. Kebschull, A. Glassner, M. Eisenhardt, and H.D. Nischalke NKp46(High) expression defines a NK cell subset that is potentially involved in control of HCV replication and modulation of liver fibrosis Hepatology 2012 Apr 24 10.1002/hep.25804
30. B. Liu, A.M. Woltman, H.L. Janssen, and A. Boonstra Modulation of dendritic cell function by persistent viruses J Leukoc Biol 85 2 2009 Feb 205 214
31. A.M. Woltman, A. Boonstra, and H.L. Janssen Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels? Gut 59 1 2010 Jan 115 125
32. E.J. Ryan, and C. O'Farrelly The affect of chronic hepatitis C infection on dendritic cell function: a summary of the experimental evidence J Viral Hepat 18 9 2011 Sep 601 607
33. J. Nattermann, H. Zimmermann, A. Iwan, M. von Lilienfeld-Toal, L. Leifeld, and H.D. Nischalke Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C Hepatology 44 4 2006 Oct 945 954
34. M. Swiecki, Y. Wang, W. Vermi, S. Gilfillan, R.D. Schreiber, and M. Colonna Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo J Exp Med 208 12 2011 Nov 21 2367 2374
35. P. Sarobe, J.J. Lasarte, N. Casares, A. Lopez-Diaz de Cerio, E. Baixeras, and P. Labarga Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins J Virol 76 10 2002 May 5062 5070
36. S.N. Waggoner, C.H. Hall, and Y.S. Hahn HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production J Leukoc Biol 82 6 2007 Dec 1407 1419
37. T. Kanto, M. Inoue, H. Miyatake, A. Sato, M. Sakakibara, and T. Yakushijin Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection J Infect Dis 190 11 2004 Dec 1 1919 1926
38. D.D. Anthony, N.L. Yonkers, A.B. Post, R. Asaad, F.P. Heinzel, and M.M. Lederman Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection J Immunol 172 8 2004 Apr 15 4907 4916
39. A. Ulsenheimer, J.T. Gerlach, M.C. Jung, N. Gruener, M. Wachtler, and M. Backmund Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection Hepatology 41 3 2005 Mar 643 651
40. A. Dolganiuc, S. Chang, K. Kodys, P. Mandrekar, G. Bakis, and M. Cormier Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection J Immunol 177 10 2006 Nov 15 6758 6768
41. K. Takahashi, S. Asabe, S. Wieland, U. Garaigorta, P. Gastaminza, and M. Isogawa Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection Proc Natl Acad Sci U S A 107 16 2010 Apr 20 7431 7436
42. B.S. Liu, Z.M. Groothuismink, H.L. Janssen, and A. Boonstra Role for IL-10 in inducing functional impairment of monocytes upon TLR4 ligation in patients with chronic HCV infections J Leukoc Biol 89 2011 Mar 8 981 988
43. F. Lechner, D.K. Wong, P.R. Dunbar, R. Chapman, R.T. Chung, and P. Dohrenwend Analysis of successful immune responses in persons infected with hepatitis C virus J Exp Med 191 9 2000 May 1 1499 1512
44. C. Neumann-Haefelin, S. McKiernan, S. Ward, S. Viazov, H.C. Spangenberg, and T. Killinger Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution Hepatology 43 3 2006 Mar 563 572
45. A. Godkin, N. Jeanguet, M. Thursz, P. Openshaw, and H. Thomas Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients Eur J Immunol 31 5 2001 May 1438 1446
46. G. Harcourt, S. Hellier, M. Bunce, J. Satsangi, J. Collier, and R. Chapman Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection J Viral Hepat 8 3 2001 May 174 179
47. A. Grakoui, N.H. Shoukry, D.J. Woollard, J.H. Han, H.L. Hanson, and J. Ghrayeb HCV persistence and immune evasion in the absence of memory T cell help Science 302 5645 2003 Oct 24 659 662
48. N.H. Shoukry, A. Grakoui, M. Houghton, D.Y. Chien, J. Ghrayeb, and K.A. Reimann Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection J Exp Med 197 12 2003 Jun 16 1645 1655
49. X.S. He, B. Rehermann, F.X. Lopez-Labrador, J. Boisvert, R. Cheung, and J. Mumm Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers Proc Natl Acad Sci U S A 96 10 1999 May 11 5692 5697
50. A.M. Grabowska, F. Lechner, P. Klenerman, P.J. Tighe, S. Ryder, and J.K. Ball Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection Eur J Immunol 31 8 2001 Aug 2388 2394
51. H.C. Spangenberg, S. Viazov, N. Kersting, C. Neumann-Haefelin, D. McKinney, and M. Roggendorf Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection Hepatology 42 4 2005 Oct 828 837
52. K.M. Chang, R. Thimme, J.J. Melpolder, D. Oldach, J. Pemberton, and J. Moorhead-Loudis Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection Hepatology 33 1 2001 Jan 267 276
53. N. Semmo, C.L. Day, S.M. Ward, M. Lucas, G. Harcourt, and A. Loughry Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection Hepatology 41 5 2005 May 1019 1028
54. A. Takaki, M. Wiese, G. Maertens, E. Depla, U. Seifert, and A. Liebetrau Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C Nat Med 6 5 2000 May 578 582
55. A. Ulsenheimer, J.T. Gerlach, N.H. Gruener, M.C. Jung, C.A. Schirren, and W. Schraut Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C Hepatology 37 5 2003 May 1189 1198
56. Y. Belkaid Regulatory T cells and infection: a dangerous necessity Nat Rev Immunol 7 11 2007 Nov 875 888
57. L.M. Fahey, E.B. Wilson, H. Elsaesser, C.D. Fistonich, D.B. McGavern, and D.G. Brooks Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells J Exp Med 208 5 2011 May 9 987 999
58. J.Y. Zhang, C.H. Song, F. Shi, Z. Zhang, J.L. Fu, and F.S. Wang Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment PLoS One 5 11 2010 e13869
59. W. Wu, J. Li, F. Chen, H. Zhu, G. Peng, and Z. Chen Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients J Gastroenterol Hepatol 25 4 2010 Apr 750 757
60. E. Billerbeck, Y.H. Kang, L. Walker, H. Lockstone, S. Grafmueller, and V. Fleming Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties Proc Natl Acad Sci U S A 107 7 2010 Feb 16 3006 3011
61. R.G. Foster, L. Golden-Mason, A. Rutebemberwa, and H.R. Rosen Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection Dig Dis Sci 57 2 2012 Feb 381 389
62. S. Grafmueller, E. Billerbeck, H.E. Blum, C. Neumann-Haefelin, and R. Thimme Differential antigen specificity of hepatitis C virus-specific interleukin 17- and interferon gamma-producing CD8(+) T cells during chronic infection J Infect Dis 205 7 2012 Apr 1142 1146
63. B. Rehermann Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence J Clin Invest 119 7 2009 Jul 1745 1754
64. P. Klenerman, and R. Thimme T cell responses in hepatitis C: the good, the bad and the unconventional Gut 61 8 2011 1226 1234
65. D. Moskophidis, F. Lechner, H. Pircher, and R.M. Zinkernagel Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells Nature 362 6422 1993 Apr 22 758 761
66. E.J. Wherry T cell exhaustion Nat Immunol 12 6 2011 Jun 492 499
67. D.L. Barber, E.J. Wherry, D. Masopust, B. Zhu, J.P. Allison, and A.H. Sharpe Restoring function in exhausted CD8 T cells during chronic viral infection Nature 439 7077 2006 Feb 9 682 687
68. H. Radziewicz, C.C. Ibegbu, M.L. Fernandez, K.A. Workowski, K. Obideen, and M. Wehbi Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression J Virol 81 6 2007 Mar 2545 2553
69. M. Pilli, A. Zerbini, A. Penna, A. Orlandini, E. Lukasiewicz, and J.M. Pawlotsky HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project) Gastroenterology 133 4 2007 Oct 1132 1143
70. G. Cai, and G.J. Freeman The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation Immunol Rev 229 1 2009 May 244 258
71. B. Bengsch, B. Seigel, M. Ruhl, J. Timm, M. Kuntz, and H.E. Blum Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation PLoS Pathog 6 6 2010 e1000947
72. V. Schlaphoff, S. Lunemann, P.V. Suneetha, J. Jaroszewicz, J. Grabowski, and J. Dietz Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells PLoS Pathog 7 5 2011 May e1002045
73. S.D. Blackburn, H. Shin, W.N. Haining, T. Zou, C.J. Workman, and A. Polley Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection Nat Immunol 10 1 2009 Jan 29 37
74. L. Golden-Mason, B.E. Palmer, N. Kassam, L. Townshend-Bulson, S. Livingston, and B.J. McMahon Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells J Virol 83 18 2009 Sep 9122 9130
75. A. Schurich, P. Khanna, A.R. Lopes, K.J. Han, D. Peppa, and L. Micco Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection Hepatology 53 5 2011 May 1494 1503
76. N. Nakamoto, D.E. Kaplan, J. Coleclough, Y. Li, M.E. Valiga, and M. Kaminski Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization Gastroenterology 134 7 2008 Jun 1927 1937 37 e1-2
77. C. Boni, A. Penna, G.S. Ogg, A. Bertoletti, M. Pilli, and C. Cavallo Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy Hepatology 33 4 2001 Apr 963 971
78. D.G. Brooks, D.B. McGavern, and M.B. Oldstone Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection J Clin Invest 116 6 2006 Jun 1675 1685
79. D.G. Brooks, M.J. Trifilo, K.H. Edelmann, L. Teyton, D.B. McGavern, and M.B. Oldstone Interleukin-10 determines viral clearance or persistence in vivo Nat Med 12 11 2006 Nov 1301 1309
80. E.M. Shevach CD4+ CD25+ suppressor T cells: more questions than answers Nat Rev Immunol 2 6 2002 Jun 389 400
81. J. Zhu, and W.E. Paul Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors Immunol Rev 238 1 2010 Nov 247 262
82. K. Sugimoto, F. Ikeda, J. Stadanlick, F.A. Nunes, H.J. Alter, and K.M. Chang Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection Hepatology 38 6 2003 Dec 1437 1448
83. T. Boettler, H.C. Spangenberg, C. Neumann-Haefelin, E. Panther, S. Urbani, and C. Ferrari T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection J Virol 79 12 2005 Jun 7860 7867
84. S.M. Ward, B.C. Fox, P.J. Brown, J. Worthington, S.B. Fox, and R.W. Chapman Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection J Hepatol 47 3 2007 Sep 316 324
85. M.A. Claassen, R.J. de Knegt, H.W. Tilanus, H.L. Janssen, and A. Boonstra Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis J Hepatol 52 3 2010 Mar 315 321
86. R. Cabrera, Z. Tu, Y. Xu, R.J. Firpi, H.R. Rosen, and C. Liu An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection Hepatology 40 5 2004 Nov 1062 1071
87. F. Bolacchi, A. Sinistro, C. Ciaprini, F. Demin, M. Capozzi, and F.C. Carducci Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels Clin Exp Immunol 144 2 2006 May 188 196
88. H. Miyaaki, H. Zhou, T. Ichikawa, K. Nakao, H. Shibata, and S. Takeshita Study of liver-targeted regulatory T cells in hepatitis B and C virus in chronically infected patients Liver Int 29 5 2009 May 702 707
89. M. Sakaki, K. Hiroishi, T. Baba, T. Ito, Y. Hirayama, and K. Saito Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis Hepatol Res 38 4 2008 Apr 354 361
90. M.A. Claassen, R.J. de Knegt, H.L. Janssen, and A. Boonstra Retention of CD4+CD25+FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans J Virol 85 11 2011 Mar 30 5323 5330
91. M.D. Rosenblum, I.K. Gratz, J.S. Paw, K. Lee, A. Marshak-Rothstein, and A.K. Abbas Response to self antigen imprints regulatory memory in tissues Nature 480 7378 2011 Dec 22 538 542
92. M.T. Brady, A.J. MacDonald, A.G. Rowan, and K.H. Mills Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes Eur J Immunol 33 12 2003 Dec 3448 3457
93. D. Accapezzato, V. Francavilla, M. Paroli, M. Casciaro, L.V. Chircu, and A. Cividini Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection J Clin Invest 113 7 2004 Apr 963 972
94. A.G. Rowan, J.M. Fletcher, E.J. Ryan, B. Moran, J.E. Hegarty, and C. O'Farrelly Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta J Immunol 181 7 2008 Oct 1 4485 4494
95. T. Kanto, T. Takehara, K. Katayama, A. Ito, K. Mochizuki, and N. Kuzushita Neutralization of transforming growth factor beta 1 augments hepatitis C virus-specific cytotoxic T lymphocyte induction in vitro J Clin Immunol 17 6 1997 Nov 462 471
96. N. Alatrakchi, C.S. Graham, H.J. van der Vliet, K.E. Sherman, M.A. Exley, and M.J. Koziel Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses J Virol 81 11 2007 Jun 5882 5892
97. D.E. Kaplan, F. Ikeda, Y. Li, N. Nakamoto, S. Ganesan, and M.E. Valiga Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis J Hepatol 48 6 2008 Jun 903 913
98. H. Kanzler, F.J. Barrat, E.M. Hessel, and R.L. Coffman Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists Nat Med 13 5 2007 May 552 559
99. J.F. Bergmann, J. de Bruijne, D.M. Hotho, R.J. de Knegt, A. Boonstra, and C.J. Weegink Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV Aliment Pharmacol Ther 34 4 2011 Aug 443 453
100. A. Boonstra, B.S. Liu, Z.M. Groothuismink, J.F. Bergmann, J. de Bruijne, and D.M. Hotho Potent immune activation in chronic hepatitis C patients upon administration of an oral inducer of endogenous interferons that acts via Toll-like receptor 7 Antivir Ther 17 4 2012 657 667